SEC Tracker
Get the app

Replimune Group REPL

Esposito Pamela (Officer) plans to sell 80,000 REPL shares, about $1.7M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Jul 10, 2023
  2. Broker: J.P. Morgan Securities LLC
  3. Shares acquired by: Stock Option Exercise
  4. 10b5-1 plan adopted: Mar 15, 2023

All of Esposito Pamela's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 17,923 shares at $21.63 on Jul 10, 2023 · Form 4
  • Sold 2,077 shares at $21.12 on Jul 10, 2023 · Form 4
  • Sold 1,400 shares at $20 on Aug 11, 2023 · Form 4
  • Sold 18,600 shares at $20.01 on Aug 22, 2023 · Form 4
  • Sold 5,358 shares at $20.01 on Sep 11, 2023 · Form 4
  • Sold 300 shares at $20 on Sep 12, 2023 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Replimune Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  2. Aldeyra Therapeutics ALDX public float $232M, Jun 30, 2025
  3. Sagimet Biosciences SGMT public float $228M, Jun 30, 2025
  4. Annexon ANNX public float $244M, Jun 30, 2025
  5. Lifecore Biomedical LFCR public float $223M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.